Protox Therapeutics Inc., a Canadian developer of treatment of urological diseases, has sealed a $15 million loan agreement with Oxford Finance. The company, which is backed by Warburg Pincus ...

VANCOUVER - Protox Therapeutics Inc. (TSX:PRX), a developer of drugs to treat urological diseases, said Monday it has entered into a US $15 million loan agreement with a U.S. lender to help the ...

Warburg Pincus made a C$8.3 million (about $8.1 million) investment in Protox Therapeutics as part of a previously agreed investment deal signed in September 2010. The agreement gives Warburg ...